Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial
NCT04883190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 353
Last updated 2024-02-28
Summary
Prospective, controlled follow-up observation of SARS-CoV-2 positive patients with regard to the aspect of fatigue (cognitive / motor) and psychological disorders in the areas of anxiety, depression and somatization.
Conditions
- SARS-CoV2 Infection
Interventions
- OTHER
-
Fulfilling Questionaires
Fulfilling Questionaires PHQ-D (brief) and FSMC
Sponsors & Collaborators
-
Hegau-Bodensee-Klinikum Singen
lead OTHER
Principal Investigators
-
Marc Kollum, PD Dr. · Hegau-Bodensee-Klinikum Singen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-15
- Primary Completion
- 2022-06-01
- Completion
- 2024-02-01
Countries
- Germany
Study Locations
More Related Trials
-
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135 ·Status: COMPLETED
-
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
NCT04887623 ·Status: RECRUITING
-
poSt Covid-19 Infection centraL Sensitisation 2
NCT04701892 ·Status: UNKNOWN
-
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
NCT04357938 ·Status: COMPLETED
-
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510 ·Status: COMPLETED
-
Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients
NCT05201625 ·Status: UNKNOWN ·Phase: NA
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
NCT05087199 ·Status: UNKNOWN
-
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
NCT06597396 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
NCT04178915 ·Status: ENROLLING_BY_INVITATION
-
Characterizing the Immune Response and Neuronal Damage in COVID-19
NCT04510012 ·Status: COMPLETED
-
Efficiency of an Optimized Care Organization for Fatigue Management for Patients With COVID-19.
NCT05236478 ·Status: COMPLETED
-
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
NCT04814914 ·Status: COMPLETED
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
NCT04456075 ·Status: UNKNOWN
-
Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
NCT04728919 ·Status: UNKNOWN
-
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome
NCT04346017 ·Status: COMPLETED ·Phase: NA
-
Multimodal Long Covid19
NCT05932797 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Pathophysiology of Long Term Implications
NCT04813575 ·Status: UNKNOWN ·Phase: NA
-
Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19
NCT04381819 ·Status: UNKNOWN
-
Clinical Presentations and Outcomes of Patients With Covid-19 Pneumonia
NCT05092555 ·Status: UNKNOWN
-
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
NCT05855395 ·Status: UNKNOWN ·Phase: NA
-
Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
NCT04649840 ·Status: COMPLETED
-
Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome.
NCT01343979 ·Status: COMPLETED
-
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
NCT04333589 ·Status: UNKNOWN ·Phase: NA